Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI

Blood

Volumn 104, Issue 4, 2004, Pages 1217-1223

  Arbab, Ali S ^a   Yocum, Gene T ^b   Kalish, Heather ^b   Jordan, Elaine K ^b   Anderson, Stasia A ^b   Khakoo, Aarif Y ^b   Read, Elizabeth J ^b   Frank, Joseph A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; NANOPARTICLE; PROTAMINE SULFATE; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LABELING; CELL MIGRATION; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; ISOTOPE LABELING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; STEM CELL;

EID: 3843053490     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-02-0655     Document Type: Article

References (28)

1. 111indium-oxine labeled human lymphocytes collected by automated apheresis. J Nucl Med. 1990;31:999-1006.
2. Griffith K, Read EJ, Carasquillo JA, et al. In vivo distribution of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma. J Natl Cancer Inst. 1989;81:1709-1717.
3. Hawrylak N, Ghosh P, Broadus J, Schlueter C, Greenough WT, Lauterbur PC. Nuclear magnetic resonance (NMR) imaging of iron oxide-labeled neural transplants. Exp Neurol. 1993;121:181-192.
4. Yeh TC, Zhang W, Ildstad ST, Ho C. In vivo dynamic MRI tracking of rat T-cells labeled with superparamagnetic iron-oxide particles. Magn Reson Med. 1995;33:200-208.
5. Dodd SJ, Williams M, Suhan JP, Williams DS, Koretsky AP, Ho C. Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys J. 1999;76:103-109.
6. Josephson L, Tung CH, Moore A, Weissleder R. High-efficiency intracellularmagnetic labeling with novel superparamagnetic-tat peptide conjugates. Bioconjug Chem. 1999;10:186-191.
7. Bulte JW, Douglas T, Witwer B, et al. Magneto-dendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol. 2001;19:1141-1147.
8. Kircher MF, Allport JR, Graves EE, et al. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res. 2003;63:6838-6846.
9. Frank JA, Zywicke H, Jordan EK, et al. Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad Radiol. 2002;9:S484-S487.
10. Frank, JA, Miller BR, Arbab AS, et al. Clinically applicable labeling of mammalian cells and stem cells by combining (FDA)-approved superparamagnetic iron oxides and commonly available transfection agents. Radiology. 2003;228:480-487.
11. Arbab AS, Bashaw LA, Miller BR, et al. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantations. 2003;76:1123-1130.
12. Hoehn M, Kustermann E, Blunk J, et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo MRI investigation of experimental stroke in rat. Proc Natl Acad Sci U S A. 2002;99:16267-16272.
13. Ferrucci JT, Stark DD. Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. AJR Am J Roentgenol. 1990;155:943-950.
14. Weissleder R, Stark DD, Engelstad BL, et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol. 1989;152:167-173.
15. Kalish H, Arbab AS, Miller BR, et al. Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces and chemical composition. Magn Reson Med. 2003;50:275-282.
16. Arbab AS, Bashaw LA, Miller BR, et al. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology. 2003;229:838-846.
17. Anderson SA, Shukaliak-Quandt J, Jordan EK, et al. Detection of magnetically labeled encephalitogenic T-cells in mouse spinal cord by cellular magnetic resonance imaging. Ann Neurol. 2004;55:654-659.
18. Arbab AS, Jordan EK, Wilson LB, Yocum GT, Lewis BK, Frank JA. In vivo trafficking and targeted delivery of magnetically labeled stem cells. Hum Gene Ther. 2004;15:351-360.
19. Kraitchman DL, Heldman AW, Atalar E, et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation. 2003;107:2290-2293.
20. Bulte JW, Zhang S, van Gelderen P, et al. Neurotransplantation of magnetically labeled oligodendrocytes progenitors: MR tracking of cell migration and myelination. Proc Natl Acad Sci U S A. 1999;96:15256-15261.
21. Moore A, Sun PZ, Cory D, Hogemann D, Weissleder R, Lipes MA. MRI of insulitis in autoimmune diabetes. Magn Reson Med. 2002;47:751-758.
22. Hill JM, Dick AJ, Raman VK, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation. 2003;108:1009-1014.
23. Daldrup-Link HE, Rudelius M, Oostendorp RA, et al. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology. 2003;228:760-767.
24. Arbab AS, Yocum GT, Wilson LB, et al. Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency and cellular viability. Mol Imaging. 2004;3:24-32.
25. Arnold LJ Jr, Dagan A, Guthel J, Kaplan NO. Antineoplastic activity of poly (I-lysine) with some ascites tumor cells. Proc Natl Acad Sci U S A. 1979;76:3246-3250.
26. Bull BS, Huse WM, Brauer FS, Korpman RA. Heparin therapy during extracorporeal circulation, II: the use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg. 1975;69:685-689.
27. Gervin AS. Complications of heparin therapy. Surg Gynecol Obstet. 1975;140:789-796.
28. Sorgi FL, Bhattacharya S, Huang L. Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther. 1997;4:961-968.